ProKidney lost $51.8 million last quarter, which is more than it lost the year before.

Nov 13, 2026, 9:17 AM ETResultsRead the original at globenewswire.com

Neutral

ProKidney's loss grew as trial and manufacturing costs rose, but it had $141.9 million in cash and its study dates remain on track. These signs point in different directions.

PROK · ProKidney Corp.

AI read · Neutral

The AI's read

Higher study and manufacturing costs help explain the larger loss, but the report does not say the study failed. The cash balance gives ProKidney funds for ongoing work, though the report does not say how long they will last. Enrollment and results are still scheduled for 2027, so progress is planned rather than proven.

Get alerts for PROK

Follow ProKidney Corp. (PROK) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for PROK

Free on the App Store and Google Play, or on the web.